License Agreements - CD47 License (Details) - CD47 License agreement with InnoBation - Curis Biotech Holdings LLC - Class A Member Units $ in Millions |
Oct. 31, 2022
USD ($)
shares
|
|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Number of member units exchange for license rights to develop, market and sell YN1203, InnoBation Bio CAR NK biomarker | shares | 78,555,554 |
| Value of membership interest offset to additional paid-in capital | $ | $ 0.8 |